Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve Intimation of Board Meeting

TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 Date: 29/09/2026 BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai – 400 001 Scrip Code: 539519 Subject: Intimation of the Board Meeting Schedule to be held on Wednesday, 07th October, 2026 under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Tavexia Lifecare Limited is scheduled to be held on Wednesday, 07th October, 2026, inter alia, to consider and discuss the following matter: - To further discuss and deliberate upon the matter relating to the proposed acquisition of up to 60% of the equity share capital of Meyonex Pharmaceuticals Limited, an unlisted public company having CIN: U74120MH2015PLC261024. The aforesaid matter is being considered with reference to the previous meeting of the Board of Directors of the Company held on Monday, 07th September, 2026, wherein the Board had considered and approved the proposal for acquisition of up to 60% of the equity share capital of Meyonex Pharmaceuticals Limited and authorised the designated representatives of the Company to undertake preliminary evaluation, due diligence, valuation and negotiations in relation thereto. The Board shall further discuss and deliberate upon the developments in the matter and decide the further course of action in relation to the proposed acquisition. - To consider and transact any other business with the permission of the Chairperson. Further, This is to informed to the exchange that in accordance with the Company’s Code of Conduct on Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, the Trading Window for dealing in the securities of the Company by the designated persons and their immediate relatives was closed from September 30, 2026 till 48 hours after the Board Meeting to be conducted for approval of the un-Audited Financial Results of the Company for the half year ended Sep 30th , 2026. Please take the same on your record and acknowledge the receipt of the same. Mumbai Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/ SSAwww.mayukh.co.in TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 Thanking You, Yours Faithfully For Tavexia Lifecare Limited (Formerly Sattva Sukun Lifecare Limited) Poonam Rani Company Secretary Mumbai Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/ SSAwww.mayukh.co.in